New chemo cocktail tested in fight against aggressive blood cancer
NCT ID NCT05906914
Summary
This study tested a new combination of three chemotherapy drugs (called CHA) for adults under 60 with newly diagnosed acute myeloid leukemia (AML), a serious blood cancer. The goal was to see how well this regimen worked to put the cancer into remission and how safe it was for patients. Researchers tracked whether the cancer cleared, how long patients lived, and if the cancer came back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
Conditions
Explore the condition pages connected to this study.